Think PINK
Drug Gets Kinase Back to Work in Parkinson's Disease
As far as targeting kinases goes, inhibition is the only game in town. But that is not because there's no need for activators.
To continue reading subscribe now to BioWorld Asia (formerly International)
Learn More about BioWorld Asia (formerly International)
Already a subscriber? Sign In or Buy now to activate your subscription
Note: our contact information has changed
Customer Care: http://support.clarivate.com
© 2018 Clarivate Analytics.
Reproduction, reposting content is strictly prohibited.
Reproduction, reposting content is strictly prohibited.